Q Chip has developed a range of proprietary fluidic devices that enable the encapsulation of a range of materials from small molecules to cells in uniform polymer microspheres (from 40 to 2000 µm diameter). Virtually any polymers can be used from crosslinked hydrogels to bioresorbable materials, enabling applications in many areas of life science including diagnostic testing, cell therapies and drug delivery.
The Q-Sphera platform will extend the possibilities for drug encapsulation and sustained release at the time when the Pharmaceutical industry is seeking both to extend product life cycles and to find the best ways to deliver novel complex biotherapeutics.
Q Chip's in-house product portfolio includes improved generic SR depots of peptides, proteins and small molecules, and the collaborative development of a sustained release Interferon alpha 2a.
